Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-21-012339

Director acquired 536 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
COHEN MARC A Director 2021-02-18 Option exercise +536 $2.11 $1,131 5,566 D
Derivatives
COHEN MARC A Director 2021-02-18 Option exercise · Stock Option (Right to Buy) −536 3,209 D
Loading xslF345X03/doc4.xml…